Company news
Shin Nippon Biomedical Laboratories, Ltd. news in 2025
Shin Nippon Biomedical Laboratories, Ltd.'s news releases, calls and decks from 2025, newest first.
Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in Headache
November 5, 2025
ガバナンスに関するデータ
August 26, 2025
Satsuma Pharmaceuticals and SNBL Announce Four Abstracts to be Presented at the American Headache Society's 67th Annual Scientific Meeting
June 19, 2025
Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
April 29, 2025